That all depends on the price. If the price is reasonable then fine. But typically big pharma that gets a lock-in on 'life' is anything but reasonable in their pricing, after all, what's the value of a human life.
The 5% profits over costs is promising, even if it leaves some wiggle room.
The 5% profits over costs is promising, even if it leaves some wiggle room.